Andrew C. von Eschenbach, M.D. took over as Commissioner of the FDA in September 2005. During his tenure, he prioritized modernization efforts within the agency, emphasizing innovation and efficiency. He spearheaded initiatives such as the Critical Path Initiative and the FDA's Food Protection Plan, aimed at enhancing public health and safety standards.

Under von Eschenbach's leadership, the FDA expanded its global footprint by establishing offices in various countries. This move aimed to strengthen international collaboration on regulatory matters and ensure the safety of imported products.

Prior to his roles at the FDA and the National Cancer Institute (NCI), von Eschenbach had a distinguished career spanning over three decades as a physician, surgeon, oncologist, and healthcare executive. His extensive experience in oncology likely informed his approach to cancer-related initiatives during his tenure at the NCI.

Health, Healthcare Policy, Men's Health, Prostate Cancer, Cancer, Healthcare, Innovation, Physician, Medicine, Oncology,